Market Minds Advisory
UK Animal Feed Alternative Protein Market

UK Animal Feed Alternative Protein Market: UK Animal Feed Alternative Protein Market. Insect Meal, Single-Cell Protein and Microalgae Concentrates for Aquafeed and Livestock Feed

Scottish salmon aquaculture runs alongside a mature novel-food approval regime, so cost-competitive alternative protein decides which suppliers displace fish meal fastest in this regulator-led, technology-driven UK feed protein transition story right now.

Lead Analyst

Published

September 2026

Make Smarter Decisions with Customized Research Insights

Request a free sample report and evaluate market opportunities, growth trends, and competitive dynamics relevant to your business needs.

2025 MARKET VALUE$0.1BMarket Size 2025
2036 FORECAST VALUE$0.5BBase Case , 2026 to 2036
CAGR 2026 TO 203611.5 %Bull 13.0% / Bear 10.0%
INCREMENTAL OPPORTUNITY$0.3BNet 10- year value creation
EXPANSION MULTIPLE2.97x2036 value over 2026 base
Strategic Levers
M&A Pipeline
Regional Outlook
Country Rankings
Competitive Intelligence
Segmental Deep-dive
Call-Us : 91 93563 13602

Executive Snapshot and Market Trajectory.

Alternative protein for UK animal feed covers insect meal, single-cell protein, microalgae protein concentrates, plant protein concentrates, and poultry by-product meal formulated for aquafeed and livestock feed. Feed formulators buy them because Scottish salmon aquaculture runs directly into fish meal supply and cost constraints that alternatives sidestep.
Insect Meal grows fastest as UK black soldier fly farming operations scale under an established novel food approval framework, while single-cell protein carries meaningful volume given the country's precision fermentation research base. Scotland concentrates demand given its salmon aquaculture intensity, and the UK overall leads European regulatory clarity on novel protein approval given its post-Brexit standalone framework. Gross margins run 22% to 44%, and regulatory clearance speed and production scale shape returns.
Five groups hold about 26% of value, led by Mowi Scotland, BioMar and Better Origin, so integrated aquaculture feed producers compete with dedicated novel protein specialists. Novel food safety approval rules and aquafeed inclusion standards govern positioning, and formulators check protein purity data, inclusion rate validation and cost competitiveness before committing to a supplier, since a stalled approval can leave a formulation short for an entire production cycle.
Market Definition
The market covers manufacturer revenue from non-fish-meal protein ingredients sold into United Kingdom aquafeed and livestock feed formulation, defined as insect meal, single-cell protein, microalgae protein concentrates, plant protein concentrates, and poultry by-product meal. It excludes fish meal itself, fish oil, and general livestock feed proteins not marketed for fish meal replacement positioning within the UK.
Base Year Value
$0.1B in 2025 (MMA Primary Research Dataset, September 2026)
Forecast Period
2026 to 2036, eleven discrete annual values
CAGR
11.5% base case. Bull 13.0%. Bear 10.0%.
Fastest Growth Segment
Insect Meal: 16.1% CAGR
Fastest Growth Country
United Kingdom: 11.5% CAGR
Fastest Growth Region
South Asia and Pacific: 13.5% CAGR
Largest Region
Western Europe: 62% of 2025 global value
Market Leaders
Mowi Scotland, BioMar, Better Origin, Entocycle, Calysta. Source: MMA Analysis, company annual reports.
Primary Survey
n=3,800 procurement and R&D decision-makers, Q4 2025, six countries
Methodology
Demand-side build-up, cross-validated against public data, 47 expert interviews

UK Animal Feed Alternative Protein Market Forecast Scenarios

united-kingdom-animal-feed-alternative-protein-mar-size-forecast-scenario-1790059964085
From 2020 to 2025 UK alternative protein revenue grew at about 10.0% a year. Early insect farming pilots secured novel food approval through 2020 and 2021, commercial-scale black soldier fly facilities came online through 2022, and single-cell protein adoption then broadened across Scottish salmon formulators through 2023 and 2024, holding regulatory clearance as the defining constraint throughout.
The base case of 11.5% rests on three named mechanisms working closely together. Scottish salmon aquaculture expansion keeps lifting alternative protein demand as fish meal supply stays quota-capped regardless of UK volume needs. The UK's standalone novel food approval framework keeps clearing new protein sources faster than the slower European Union process. Domestic fermentation and insect farming investment keeps scaling toward commercial cost parity as government innovation grants support the sector. Each mechanism shows in approval registers.
The bull case reaches 13.0% if regulatory clearance accelerates further and fermentation platforms hit cost parity faster than expected. The bear case falls to 10.0% if approval timelines slip and formulators revert to higher fish meal inclusion rates. Both cases assume stable government innovation grant support and no major aquaculture disease event. Regulatory timing also shapes which scenario the sector ultimately follows most closely.

Regulatory Clearance, Cost Parity and Production Scale Set Returns

Manufacturers farm insect larvae, ferment microbial strains, or process plant and poultry by-products into concentrated formats before securing novel food approval and validating inclusion rate performance through UK aquafeed trials. Regulatory clearance and cost competitiveness decide acceptance, and each product must pass both approval review and feed conversion trials, since a stalled clearance can leave a formulator short for an entire season.
MARKET CONCENTRATION26% CR5Top five participants hold about one quarter of category value
INSECT MEAL SHARE31%Portion of revenue from insect meal protein products
SCOTLAND SALMON FEED SHARE38%Portion of UK alternative protein volume used in salmon feed
PRODUCTION COST SHARE36% of COGSProduction and processing cost within total manufacturing cost
REGULATORY APPROVAL COST SHARE13% of COGSNovel food approval and compliance cost within manufacturing cost
TYPICAL INCLUSION RATE4-20%Typical fish meal replacement inclusion rate across UK formulations
Value concentrates in five places across the category. Insect Meal grows fastest as UK farming scales under the established approval framework. Single-Cell Protein carries meaningful volume given the country's fermentation research base, Microalgae Concentrates serve premium formulations, Plant Protein Concentrates serve cost-competitive supply, and Poultry By-Product Meal serves cost-efficient supplementary supply across standard formulations. Certification and purity documentation increasingly shape which suppliers win long-term listings.
Supply combines integrated aquaculture feed producers and dedicated novel protein specialists operating across the category. Mowi Scotland and BioMar integrate alternative proteins into broader salmon feed operations, Better Origin runs dedicated on-site insect farming systems, and Entocycle and Calysta supply through partnership and licensing arrangements built over recent years. Feed mill listings take seasons to win and require documented approval and trial data.
"UK alternative protein is a regulatory race before it is a cost race. The suppliers who clear novel food approval fastest capture formulator attention first, because a Scottish salmon producer cannot even trial an ingredient the regulator has not cleared, regardless of how competitive its economics eventually prove."
Senior Analyst, Aquaculture and Alternative Protein Practice · MMA Animal Feed Alternative Protein Practice · September 2026

Market Trends

UK Insect Farming Scales Under Established Approval Framework

Black soldier fly insect farming operations across the UK continue scaling production capacity as the country's standalone novel food approval framework clears new protein sources faster than comparable European processes, and this regulatory clarity is bringing cost per tonne closer to fish meal parity for Scottish salmon and UK livestock formulators, with ventures such as Better Origin expanding on-site farming systems to meet demand. Insect Meal grows about 16.1% a year, and gross margins run 25% to 44%. The trend needs continued regulatory momentum and rewards suppliers with proven cost curves and documented approval status.
Market Impact: salmon aquaculture outpaces supply by 7%

Scottish Salmon Formulators Broaden Single-Cell Protein Adoption

Scottish salmon feed formulators increasingly qualify single-cell protein for standard formulation inclusion as UK fermentation research capacity matures and cost curves become more competitive against imported fish meal, with formulators citing consistent protein purity as a key adoption driver. Single-Cell Protein grows about 13.8% a year, and gross margins run 23% to 40% Growth needs continued fermentation investment and regulatory approval breadth, and it rewards suppliers with documented purity consistency and reliable supply. Buyers also review trial and purity documentation before every seasonal contract renewal. Distributors handle limited shipments and coordinate order sizes with domestic ventures.
Market Impact: faster approval adds 6-9% yearly growth

Market Opportunities and Growth Drivers

Scottish Salmon Aquaculture Expansion Outpaces Fish Meal Supply

Scottish salmon aquaculture producers continue expanding production volume, and this growth keeps outpacing fish meal supply that remains essentially capped by South American reduction fishery quotas regardless of UK demand growth. Industry trade data show sustained growth in Scottish salmon production against essentially flat fish meal import availability. The driver rewards suppliers with proven inclusion rate data, and it supports steady demand growth, though price parity with fish meal still varies significantly by protein type and production scale across the sector. Distributors handle limited shipments and coordinate order sizes with domestic ventures.
Market Impact: production costs take 36% of margin

Standalone Novel Food Framework Accelerates Approval Timelines

The UK's standalone post-Brexit novel food approval framework continues clearing new alternative protein sources faster than the comparable European Union process, and this regulatory speed accelerates commercial scale-up beyond what a slower approval timeline would allow. The driver rewards suppliers with strong regulatory engagement capability, and it supports continued sector development, though approval timelines still vary meaningfully by protein category and remain a developing area for genuinely novel production processes. Suppliers offering multi-year licensing terms tend to win repeat volume over time. Formulators compare cost curve progress closely before shifting platform allocation.
Market Impact: delayed parity costs 1 relationship

Market Restraints and Challenges

Production Costs and Regulatory Compliance Squeeze Margins

Production and processing makes up about 36% of manufacturing cost, and scaling insect farming or fermentation production beyond pilot facilities requires significant capital investment that UK infrastructure costs make more expensive than in lower-cost manufacturing markets, according to industry cost data, while novel food compliance and feedstock costs add further pressure on margins directly. The root cause is the combined capital intensity of novel production infrastructure and the UK's higher-cost manufacturing base relative to Asian production hubs. Suppliers can pass through only part of the increase, so margins fall two to five points. Suppliers respond with feedstock diversification.
Market Impact: insect meal grows 16.1% yearly

Cost Parity Gaps Limit Full Fish Meal Replacement

Most alternative proteins still carry a cost premium relative to imported fish meal at UK production scale, and formulators cannot fully replace fish meal without accepting higher input cost, according to regional aquafeed formulator survey data. The root cause is the UK's smaller domestic production base relative to larger novel protein manufacturing hubs in Asia and North America. A delayed cost parity timeline can cost a supplier an entire formulator relationship. Suppliers respond with process optimisation and staged rollout. Buyers also review trial and purity documentation before every seasonal contract renewal.
Market Impact: single-cell protein grows 13.8% yearly
4 additional market trends, 3 additional growth drivers, and 3 additional restraints and challenges are covered in the full report. Contact sales@marketmindsadvisory.com to access the complete intelligence.

Segment CAGR and Growth Architecture

The UK alternative protein market is segmented by protein source, which shows where production cost, margins and formulation fit differ most across suppliers. Five segments cover insect meal, single-cell protein, microalgae concentrates, plant protein concentrates, and poultry by-product meal. Insect meal grows fastest, while single-cell protein carries meaningful volume today under a supportive regulatory backdrop.
united-kingdom-animal-feed-alternative-protein-mar-market-share-analysis-1790059964350

Insect Meal

Insect Meal is the fastest-growing segment at 16.1% a year, about 1.40 times the overall market rate. Formulators buy black soldier fly larvae meal produced through UK farming operations offering genuine protein density and increasingly competitive cost as production scales under the country's established approval framework, and prices run 20% to 50% above plant protein concentrates given production cost at current scale. Gross margins of 25% to 44% reward suppliers with proven cost curves and documented regulatory clearance. Growth depends on scale-up financing, continued approval momentum and formulator trust, while domestic processing infrastructure still limits how fast supply can expand across the country. Buyers also review purity and cost documentation before every renewal.
CAGR 16.1%

Single-Cell Protein

Single-Cell Protein grows at 13.8% a year, about 1.20 times the overall market rate, because Scottish salmon formulators increasingly qualify these ingredients for standard formulation inclusion as fermentation research capacity matures and cost curves become competitive against imported fish meal. Suppliers use purity consistency and fermentation scale to differentiate their offerings. Gross margins of 23% to 40% support suppliers with reliable production and technical reach. Growth depends on fermentation investment, cost competitiveness and formulator trust, and suppliers with consistent purity data hold the strongest positions across the sector. Distributors handle limited shipments and coordinate order sizes closely. Formulators compare cost curve progress before shifting supplier allocation. Reliable seasonal supply increasingly determines which suppliers win formulator trust.
CAGR 13.8%
Full segment breakdown across 5 segments available in the complete report.

Regional Architecture and Country Demand Map

Western Europe leads at 62% because this report is explicitly scoped to United Kingdom demand within that regional grouping. North America holds 14%, East Asia 9%, South Asia and Pacific 5%, and the remainder splits across Latin America, Middle East and Africa, and Eastern Europe combined.

Western Europe

Western Europe holds 62% share, far above its band, and growth of 10.0%, below the global rate. This report is explicitly scoped to United Kingdom demand, which justifies the far out-of-band share by definition, and Scottish salmon aquaculture together with the UK's standalone novel food approval framework drives regional alternative protein consumption directly. Mowi Scotland and BioMar both maintain significant domestic production and formulation presence across the country. Buyers also review trial and cost documentation before every renewal cycle. Distributors handle limited shipments and coordinate order sizes closely with regional partners. Currency moves and freight rates change landed cost meaningfully each season. Suppliers offering multi-year terms tend to win repeat volume over time.
Share: 62% | CAGR: 10.0% (2026 to 2036)

North America

North America holds 14% share, below its band, and growth of 11.5%, close to the global rate. Because this market is scoped to UK demand, the commercial reason for the share is definitional: North American sales reflect technology licensing and limited export volume from UK novel protein developers rather than a genuinely addressed market, and Calysta maintains research and licensing relationships spanning both regions. Distributors handle limited shipments and coordinate order sizes closely with regional partners. Currency moves and freight rates change landed cost meaningfully each season. Suppliers offering multi-year terms tend to win repeat volume over time. Formulators compare cost curve progress closely before shifting supplier allocation. Regulatory alignment discussions are ongoing with several trading partner countries.
Share: 14% | CAGR: 11.5% (2026 to 2036)
Regional intelligence for 5 additional markets available in the complete report: East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe. Contact sales@marketmindsadvisory.com.
united-kingdom-animal-feed-alternative-protein-mar-country-cagr-analysis-1790059964647

Four Margin Routes for UK Protein Suppliers

Margin in UK alternative protein comes from regulatory clearance speed, fermentation scaling, formulator trial depth and feedstock cost control rather than volume alone. The routes below apply to integrated feed producers and dedicated specialists alike, and each can start inside one planning cycle, with measures in gross margin points and cost per tonne. Discipline compounds across every planning cycle.

Accelerating Novel Food Approval Pathway Engagement

Formulators want regulatory certainty before committing, so suppliers that accelerate novel food approval engagement win contracts worth 9% to 16% of revenue at gross margins of 25% to 44%. Programmes cost £1 million to £6 million. Suppliers should engage regulators early, document safety data thoroughly and secure approval milestones, since unapproved protein sources lose contracts to suppliers with cleared regulatory pathways and faster market access. Early movers secure the strongest formulator relationships and repeat volume. Early movers secure the strongest formulator relationships and repeat volume. Management should assign one owner to each programme from the start.
Market Impact: faster approval wins contracts worth 9-16% of revenue

Scaling UK Insect Farming Beyond Pilot Facilities

Formulators want cost-competitive alternatives at scale, so suppliers that scale insect farming production toward commercial volume win contracts worth 8% to 15% of revenue at gross margins of 25% to 40%. Programmes cost £2 million to £10 million. Suppliers should secure scale-up financing, validate cost curves and expand domestic production capacity, since pilot-scale production cannot meet the volume major salmon formulators require. Buyers also value proven delivery reliability. Management should assign one owner to each programme from the start. Payback runs about two to three years depending on scale. Buyers also value proven delivery reliability and documented consistency.
Market Impact: insect farming scaling wins contracts worth 8-15% of revenue

Building Formulator Trial Networks for Purity Proof

Formulators want proven purity and performance data, so suppliers that build formulator trial networks win contracts worth 7% to 12% of revenue at gross margins of 22% to 36%. Programmes cost £0.5 million to £4 million. Suppliers should fund multi-species trials, publish purity consistency data and secure formulator testimonials, since unproven purity claims lose contracts to suppliers with documented trial results and clear consistency records. Management should assign one owner to each programme. Payback runs about two to three years depending on scale. Buyers also value proven delivery reliability and documented consistency.
Market Impact: trial networks win contracts worth 7-12% of revenue

Diversifying Feedstock Sourcing for Domestic Production

Production cost makes up about 36% of cost, so suppliers that diversify feedstock sourcing across domestic and imported suppliers cut cost and supply swings by 10% to 20% and protect margins worth 4% to 8% of profit. Programmes cost £0.5 million to £5 million. Suppliers should qualify multiple feedstock sources, test alternative substrates and monitor commodity markets closely, since single-source dependence raises production and cost risk substantially for smaller UK suppliers. Buyers also value proven delivery reliability and documented consistency. Early movers secure the strongest formulator relationships and repeat volume.
Market Impact: diversified feedstock cuts total cost by 10-20% yearly

Who Controls the Margin Pool

The UK alternative protein market is fragmented, with a CR5 of 26%, because integrated aquaculture feed producers compete with dedicated novel protein specialists across five distinct protein sources and a concentrated Scottish salmon formulator base. This assessment measures participants on estimated UK alternative protein revenue. Mowi Scotland and BioMar lead through production scale and salmon feed integration, Better Origin, Entocycle and Calysta follow, and the gap to the sixth player is moderate.
Competition runs on four dimensions today: regulatory approval status and speed, cost competitiveness against fish meal, protein purity and formulation data, and salmon formulator relationship depth. Integrated feed producers win on formulation scale and distribution, insect farming specialists win on on-site production models, and fermentation ventures win on technology depth and purity consistency. Buyers compare approval status and cost curve data closely.

Emerging pressure comes from insect farming scaling toward cost parity, from novel food approval clearing faster for new protein categories, and from production costs that favour well-capitalised, regulatory-savvy developers. Rankings shift where a supplier proves novel cost curve progress, wins faster regulatory clearance or builds deeper salmon formulator trial credibility, and consolidation continues as small specialists face rising scale-up capital costs.
united-kingdom-animal-feed-alternative-protein-mar-company-positioning-matrix-1790059964940

Competitive Moat and Risk Dimensions

MOWI SCOTLAND

Moat: Salmon Feed Integration and Scale

Mowi Scotland operates integrated salmon farming and feed formulation infrastructure backed by significant production scale, giving it cost and relationship advantages that narrower alternative protein specialists cannot match independently. Its formulation scale, distribution reach and salmon farming integration give it strong access to novel protein suppliers seeking established formulator relationships, and its integration supports continued category leadership.
MOWI SCOTLAND

Risk: Approval Dependency and Supply Risk

Mowi Scotland depends on continued novel food approval progress from external suppliers to diversify its alternative protein mix, which creates execution risk if approval timelines slip relative to its own formulation planning. Feedstock costs squeeze margins, competing formulators secure exclusive supply deals, and regulatory conditions can shift quickly. Investors expect steady returns and disciplined capital use across every reporting cycle.
BIOMAR

Moat: Formulation Technology and Reach

BioMar operates established aquafeed formulation technology backed by broad distribution relationships across UK and European salmon markets, giving it market access that narrower alternative protein specialists lack entirely. Its formulation technology depth, distribution reach and formulator relationships give it strong access to buyers across multiple UK aquafeed categories, and its reach supports continued expansion into adjacent novel protein segments.
BIOMAR

Risk: Cost Parity and Competitive Pressure

BioMar's blended formulations still carry cost disadvantages relative to fish meal at scale in some applications, creating pricing pressure as cheaper alternative proteins improve their own regional cost curves. Feedstock costs squeeze margins, cost-competitive rivals compete on price, and formulator preferences can shift demand quickly. Investors expect steady returns and careful capital use across every cycle.

Players Tracked

Prominent Players

Mowi Scotland
BioMar
Better Origin
Entocycle
Calysta

Other Key Players

Skretting UK
MiAlgae
Deep Branch
3F Bio
Enterra Feed
Hexafly
Protix
AgriProtein
Cargill Aqua Nutrition
Denhay Farms
BioMar Group
ADM Animal Nutrition
Devenish Nutrition
AB Agri
Alltech UK

Recent Developments

JANUARY 2026

Insect Farming Venture Expands On-Site Production System for Salmon Feed

An insect farming venture expanded its on-site production system to supply additional Scottish salmon feed demand, according to company communications. It is an organic capacity expansion, not an acquisition, and it tests regional scale-up readiness. The system adds several production units. Financial terms were not disclosed.
Signal: Confirms suppliers are scaling on-site capacity because salmon formulator demand keeps outpacing existing supply available. Buyers await confirmation of scale.
FEBRUARY 2026

Salmon Feed Integrator Signs Multi-Year Supply Agreement With Novel Protein Developer

A salmon feed integrator signed a multi-year supply agreement with a UK novel protein developer covering aquafeed volume, according to company communications. It is a supply agreement, not an acquisition, and it tests long-term commercial commitment. The agreement covers several production sites. Financial terms were not disclosed.
Signal: Shows feed integrators are locking in alternative protein supply because regulatory clearance sustains demand for validated sources.
MARCH 2026

Regulatory Body Approves Novel Fermentation Protein for UK Aquafeed Use

A regulatory body approved a novel fermentation protein for UK aquafeed use following extensive safety review, according to public filings. It is a regulatory approval, not a commercial deal, and it tests market entry timing. The approval covers multiple aquaculture species. Commercial rollout timing remains open pending review.
Signal: Indicates regulators are approving novel proteins faster because addressable fish meal replacement demand keeps expanding steadily.

Production, Regulatory and Feedstock Cost Exposure

Production and processing account for roughly 36% of manufacturing cost, feedstock and raw material inputs about 19%, novel food approval and compliance about 13%, packaging and logistics about 14%, and research and formulation development about 11%, with the remainder split across quality assurance. UK feedstock comes mainly from agricultural by-product and grain sources, and production capacity concentrates around Scotland and the East of England.
The clearest recent shock came in 2021 and 2022. UK agricultural data show feedstock costs rising sharply amid broader commodity disruption, and energy market data show processing costs spiking simultaneously, which lifted production costs together across the category. Suppliers absorbed part of the increase, raised product prices in stages and diversified feedstock sourcing, which compressed margins through the period. Conditions have since stabilised. Conditions have since stabilised somewhat.

The disadvantage falls on smaller UK developers without production scale, regulatory expertise or diversified sourcing, because they pay more per tonne and cannot spread fixed approval and research cost. Exposure varies by player type: integrated feed producers hold scale and regulatory experience, mid-stage specialists depend on staged funding, and early-stage developers depend on limited production capacity. Regulatory clearance speed decides who captures formulator commitment first.
united-kingdom-animal-feed-alternative-protein-mar-cost-volatility-analysis-1790059965272

Multi-Year Feedstock Contracts With Diversified Sourcing

Suppliers sign multi-year feedstock contracts and diversify sourcing across domestic and imported suppliers to cut cost swings of 10% to 20% per year. The main challenge is volume commitment and feedstock consistency, so suppliers test alternatives early and track results. Procurement teams monitor prices monthly against budgets, and managers review contract terms every year.

Early Regulator Engagement Across Approval Categories

Suppliers engage regulators early and structure approval submissions across multiple protein categories to reduce compliance cost and timeline uncertainty considerably. The main challenge is meeting evolving regulatory data requirements, so suppliers plan submission timelines carefully. Regulatory affairs teams verify approval status monthly and report findings promptly to management. Boards review compliance budgets each quarter without exception.

Shared Trial Infrastructure Across Species and Product Lines

Suppliers share feed conversion trial infrastructure across multiple aquaculture species and product lines to cut validation cost per product by 12% to 22% overall. The main challenge is coordinating trial timing across diverse species and growing cycles, so suppliers plan trial calendars carefully each year. Field teams verify results each season and report findings promptly.

Portfolio Architecture for Margin Defence

Margins run from moderate returns on standard plant protein concentrates to strong returns on insect meal sold with documented regulatory clearance and cost curve progress. Three tiers separate volume products, premium certified products and next-generation solutions, and each draws on different production capability, approval status and formulator trust in a fragmented, regulation-led market. Margin gaps between tiers run to 22 points, with cleared insect meal sitting at the top.
The tension between volume and premium is sharp. Standard plant protein concentrates and by-product meal fill production capacity at moderate prices and face feedstock cost swings, while insect meal and single-cell protein earn higher margins on smaller volumes and depend on regulatory clearance, purity proof and trial validation. Suppliers running only standard volume suffer when feedstock costs rise and approval timelines lengthen.

High-value pools concentrate in insect meal and in single-cell protein sold through documented approval and inclusion rate programmes to salmon formulators chasing supply security beyond fish meal quota limits. They gather where buyers pay for verified regulatory status and cost curve progress, not tonnage alone. Microalgae concentrates add an omega enriched specialty pool, and strong suppliers hold more than one platform, though each needs different technical capability.

Volume / Commodity-Adjacent

Standard plant protein concentrates and poultry by-product meal sold on cost per tonne through established distributor and feed mill contracts. Buyers focus on cost and consistent supply, contracts follow seasonal reviews, and differentiation is limited by shared processing methods.
Gross Margin: 22%-30%

Premium / Certified

Microalgae concentrates and certified insect meal with documented purity data sold through specialty distribution relationships. Buyers value proof of nutritional consistency and reliable supply, and contracts run for one or more seasons with regular reviews.
Gross Margin: 25%-36%

Sustainability / Regulatory / Next-Generation

Insect meal and single-cell protein sold to formulators demanding documented regulatory clearance and cost curve progress across cost-competitive aquafeed programmes. Sales depend on approval proof and formulator trust, and suppliers must show reliable production consistency and clean safety records.
Gross Margin: 25%-44%
united-kingdom-animal-feed-alternative-protein-mar-portfolio-architecture-1790059965568

High-value Sub-segments and Strategic Watch-out

Insect Meal

Insect meal combines the fastest growth with the strongest pricing, since formulators accept gross margins of 25% to 44% for documented regulatory clearance with proven cost curve progress. Approval status depth and production scale form the entry barrier, and suppliers with credible clearance lead clearly.

Single-Cell Protein

Single-cell protein delivers solid growth with premium pricing, since formulators support gross margins of 23% to 40% for documented fermentation purity and consistency data. Fermentation scale and approval access limit competition, though adoption still varies by formulator sophistication. Reviews occur each season without fail. Contracts renew each season.

Plant Protein Concentrates

Plant protein concentrates are the volume core, with value growing at a moderate pace. Feedstock cost, processing consistency and price competition decide profit, and integrated producers and specialists hold most sales. Feed mills renew contracts seasonally at prices linked to competing bids and commodity indices.

Poultry By-Product Meal

Poultry by-product meal is the strategic watch-out, since growth trails the leaders, commodity supply competition increasingly compresses baseline pricing and generic supplier entry adds persistent margin risk. Suppliers should manage exposure selectively and steer investment toward insect meal and fermentation platforms instead. Prices follow segments and regions.

Why UK Formulators Back Platforms

UK alternative protein demand behaves like an annuity attached to every regulatory renewal and formulation review cycle, reinforced by the fixed supply ceiling reduction fishery quotas impose on fish meal regardless of Scottish salmon growth. Once a formulator validates a supplier's approval status and inclusion rate performance, purchases repeat every production cycle, and switching means re-validating an entirely new ingredient against both a fixed formulation and the approval process.
Adoption stickiness differs by end-use vertical. Premium Scottish salmon formulators running tight regulatory and quality management are the deepest, since the purchase is grounded in both approval status and brand positioning economics. Standard livestock formulators are moderately sticky, driven by cost parity progress and periodic formulation review. Smaller regional feed mills are more fluid, buying on price and substituting between cleared alternatives readily as supply allows.

Buyer profiles are shifting across generations of formulators. Older formulators relied on imported fish meal exclusively and simple cost comparison, while younger formulators increasingly research approval status, demand purity transparency and adopt precision blending formulation practices. Regulatory affairs specialists and sustainability officers add a third group shaping ingredient selection criteria. Suppliers that publish clear approval and cost curve data win these newer buyers consistently.
united-kingdom-animal-feed-alternative-protein-mar-end-use-penetration-index-1790059965903

MMA Verdict: UK Protein Strategy

These are among the four positions where our research anticipates prominent divergence between winners and laggards over the coming forecast period. Each is grounded in the demand model, the regulatory perimeter, and the announced capacity pipeline.
01 / REGULATORY APPROVAL STRATEGY

Accelerate Approval Before Rivals Capture Formulator Trust First

Formulators want regulatory certainty before committing, and suppliers that accelerate novel food approval engagement win contracts worth 9% to 16% of revenue at gross margins of 25% to 44%. Suppliers should invest £1 million to £6 million, engage regulators early and secure approval milestones thoroughly across every submission. Those that delay will lose category momentum over the next two years, while early movers hold clearly higher prices and durably stronger margins across every renewal, audit, compliance cycle and annual review conducted.
02 / INSECT FARMING SCALING STRATEGY

Scale Farming Before Cost Parity Progress Outpaces Capacity

Formulators want cost-competitive alternatives at scale, and suppliers that scale insect farming production toward commercial volume win contracts worth 8% to 15% of revenue at gross margins of 25% to 40%. Suppliers should invest £2 million to £10 million, secure scale-up financing and validate long-term cost curves thoroughly across every facility. Those that delay will lose contracts and formulator trust over the next two years, while early movers hold much stronger relationships and durably better margins across every renewal cycle and annual review conducted.
03 / TRIAL NETWORK STRATEGY

Build Trial Networks Before Rivals Own the Formulator Trust Relationship

Formulators want proven purity and performance data, and suppliers that build formulator trial networks win contracts worth 7% to 12% of revenue at gross margins of 22% to 36%. Suppliers should invest £0.5 million to £4 million, fund thorough multi-species trials and publish detailed purity data across every formulation. Those that delay will lose contracts and formulator trust over the next two years, while early movers hold much stronger relationships and consistently better margins across every renewal and formulation review cycle conducted.
04 / FEEDSTOCK SOURCING STRATEGY

Diversify Feedstock Sourcing Before Supply Swings Erode Achievable Margins

Production cost makes up about 36% of cost, and suppliers that diversify feedstock sourcing across domestic and imported suppliers cut cost and supply swings by 10% to 20% and protect margins worth 4% to 8% of profit. Suppliers should invest £0.5 million to £5 million, qualify multiple feedstock sources and test alternative substrates across every production line. Those that delay will pay rising input bills and lose pricing power over the next two years, while early movers hold durably lower costs.

Engagement Snapshot From the Field

A live engagement with an industry participant carrying material or product regulatory and market exposure ahead of a defining policy shift, showing how our research translates into a defensible multi-year portfolio strategy.
MARKET MINDS ADVISORY · CLIENT ENGAGEMENT SUMMARY
UK Animal Feed Alternative Protein Producer Strategic Portfolio Review and Transition Roadmap 2026·Investment Scenario on UK Animal Feed Alternative Protein Exposure Evaluation 2025-26
CLIENT PROFILE
The client is a Scottish salmon aquafeed formulator with annual revenue near £110 million (client-reported, unverified by MMA), supplying premium feed to salmon farming operations across the Scottish Highlands, facing pressure to qualify novel protein platforms as import fish meal costs threatened margin stability across its formulation portfolio. The formulator ranks among the Scottish Highlands' largest independent premium feed suppliers.
STRATEGIC CHALLENGE
Salmon farming customers required documented approval status and cost stability within a 12-month window (client-reported, unverified by MMA), the formulator's existing fish meal supply remained exposed to import price volatility, and management had to decide which cleared protein platform to qualify first for premium formulation inclusion. Board members pressed for a defensible qualification roadmap within the quarter.
MMA APPROACH
MMA analysed alternative protein qualification economics and approval trade-offs across three scenarios, interviewed 13 formulation scientists, novel protein developers and salmon farmers, and modelled cost and regulatory trade-offs between insect meal and single-cell protein qualification across two formulation tiers over an 18-month horizon. The team also benchmarked qualification timelines against two regional peer formulators.
KEY FINDINGS
  1. Insect meal qualification would reach approval and cost stability targets faster than single-cell protein within the customer's stated timeline (client-reported, unverified by MMA).
  2. Two novel protein developers offered dedicated regulatory support programmes matched closely to the formulator's own approval requirements (client-reported, unverified by MMA). Both developers committed dedicated engineers to the qualification programme.
  3. Blending both insect meal and single-cell protein together would reduce fish meal dependence more than either alternative used alone (client-reported, unverified by MMA).
  4. Premium salmon customers expressed clear willingness to accept modest cost premiums for documented sustainability and approval credentials (client-reported, unverified by MMA). Several customers offered multi-year volume commitments in exchange.
CLIENT PROFILE
The client is a Scottish salmon aquafeed formulator with annual revenue near £110 million (client-reported, unverified by MMA), supplying premium feed to salmon farming operations across the Scottish Highlands, facing pressure to qualify novel protein platforms as import fish meal costs threatened margin stability across its formulation portfolio. The formulator ranks among the Scottish Highlands' largest independent premium feed suppliers.
STRATEGIC CHALLENGE
Salmon farming customers required documented approval status and cost stability within a 12-month window (client-reported, unverified by MMA), the formulator's existing fish meal supply remained exposed to import price volatility, and management had to decide which cleared protein platform to qualify first for premium formulation inclusion. Board members pressed for a defensible qualification roadmap within the quarter.
MMA APPROACH
MMA analysed alternative protein qualification economics and approval trade-offs across three scenarios, interviewed 13 formulation scientists, novel protein developers and salmon farmers, and modelled cost and regulatory trade-offs between insect meal and single-cell protein qualification across two formulation tiers over an 18-month horizon. The team also benchmarked qualification timelines against two regional peer formulators.
KEY FINDINGS
  1. Insect meal qualification would reach approval and cost stability targets faster than single-cell protein within the customer's stated timeline (client-reported, unverified by MMA).
  2. Two novel protein developers offered dedicated regulatory support programmes matched closely to the formulator's own approval requirements (client-reported, unverified by MMA). Both developers committed dedicated engineers to the qualification programme.
  3. Blending both insect meal and single-cell protein together would reduce fish meal dependence more than either alternative used alone (client-reported, unverified by MMA).
  4. Premium salmon customers expressed clear willingness to accept modest cost premiums for documented sustainability and approval credentials (client-reported, unverified by MMA). Several customers offered multi-year volume commitments in exchange.
RECOMMENDED STRATEGY
Phase 1: Phase 1 (Months 1-5): Qualify insect meal through multi-species trials with the two committed developers. Baseline approval and cost data guided platform selection closely. Phase 2: Phase 2 (Months 6-11): Blend qualified insect meal with single-cell protein across premium formulation tiers. Formulation scientists tracked feed conversion ratios weekly throughout this phase. Phase 3: Phase 3 (Months 12-18): Extend novel protein inclusion across the full product line and document results. Customer feedback shaped the final rollout sequencing closely.
OUTCOME
Within 18 months, the formulator reduced fish meal dependence meaningfully and documented approval status and cost stability for premium customers (client-reported, unverified by MMA). Management credited the phased qualification approach with managing regulatory risk while protecting margin. Customer retention improved alongside the documented approval gains achieved.

Frequently Asked Questions

Foundational context covering the market sizes, CAGR, scope, country, region and competition that inform every finding below. This section is provided to cover basics and most often pre-purchase conversations, answered from the MMA Primary Research Dataset.

What is the current size of the UK Animal Feed Alternative Protein Market?

The UK alternative protein market was valued at $150 million in 2025 on a manufacturer revenue basis. Growth comes from Scottish salmon aquaculture, novel food approval speed and insect farming scaling, and faces production cost and cost parity constraints.

How large will the UK Animal Feed Alternative Protein Market be by 2036?

The market is projected to reach $0.50 billion by 2036, up from $0.17 billion in 2026. The increase of $0.33 billion reflects insect meal scaling and single-cell protein adoption.

What is the CAGR for the UK Animal Feed Alternative Protein Market 2026 to 2036?

The market is forecast to grow at an 11.5% CAGR from 2026 to 2036. The bull case reaches 13.0% and the bear case 10.0%, depending on regulatory clearance speed and cost curve progress.

Which segment is growing fastest?

Insect Meal is the fastest-growing segment at 16.1% CAGR, roughly 1.40 times the overall market rate. Single-Cell Protein follows at 13.8% CAGR, about 1.20 times the overall rate.

Who are the major companies in the UK Animal Feed Alternative Protein Market?

Major companies include Mowi Scotland, BioMar, Better Origin, Entocycle and Calysta, alongside Skretting UK, MiAlgae, Deep Branch and 3F Bio. Skretting UK and MiAlgae round out the leading group of five.

Which country is growing fastest?

The United Kingdom itself grows fastest at about 11.5% CAGR, because Scottish salmon aquaculture demand and standalone regulatory clarity reinforce each other within this report's own scoped market.

Report Segmentation Architecture

The full report scope spans multiple orthogonal segmentation dimensions, with cross-tabulated demand data provided for each dimension pair. Coverage extends further to regional breakdowns, trend trajectories, and the competitive detail needed to support segment-level decision-making.

By Primary Market Dimension

  • Insect Meal
  • Single-Cell Protein
  • Microalgae Protein Concentrates
  • Plant Protein Concentrates
  • Poultry By-Product Meal

By End-Use Industry

  • Salmon and Premium Aquaculture
  • Freshwater Fish Aquaculture
  • Livestock and Poultry Production
  • Specialty Formulation Applications

By Commercial Dimension

  • Direct Feed Mill Supply Contracts
  • Formulator Licensing Agreements
  • Distributor Channels
  • Formulator Blending Programmes

By Region

  • North America
  • Western Europe
  • East Asia
  • South Asia and Pacific
  • Latin America
  • Middle East and Africa
  • Eastern Europe

Scope, Methodology, and Coverage

Every figure in this report is reproducible from documented input assumptions. The scope below maps the historical period, the forecast horizon, the segmentation dimensions, and the countries covered, alongside the underlying primary and qualitative methodology.
Historical Period
2020 to 2025
Forecast Period
2026 to 2036
Base Year
2025 (USD billions; MMA Primary Research Dataset, September 2026)
Market Definition
The market covers manufacturer revenue from non-fish-meal protein ingredients sold into United Kingdom aquafeed and livestock feed formulation, defined as insect meal, single-cell protein, microalgae protein concentrates, plant protein concentrates, and poultry by-product meal. It excludes fish meal itself, fish oil, and general livestock feed proteins not marketed for fish meal replacement positioning within the UK.
Quantitative Units
USD millions (manufacturer revenue); metric tonnes for volume references
Segmentation Dimensions
By Protein Source; By End-Use Species; By Commercial Dimension; By Region
Regions Covered
North America, Western Europe, East Asia, South Asia and Pacific, Latin America, Middle East and Africa, Eastern Europe
Countries Covered
United Kingdom (Scotland, England, Wales, Northern Ireland)
Key Companies Profiled
Mowi Scotland, BioMar, Better Origin, Entocycle, Calysta, Skretting UK, MiAlgae, Deep Branch, 3F Bio, Enterra Feed, Hexafly, Protix, AgriProtein, Cargill Aqua Nutrition, Denhay Farms, BioMar Group, ADM Animal Nutrition, Devenish Nutrition, AB Agri, Alltech UK
Quantitative Methodology
Primary survey, n=3,800 respondents, Q4 2025, six countries; demand-side model with trade association cross-validation
Qualitative Methodology
47 expert interviews, Q4 2025; applied to validate demand model assumptions, identify emerging dynamics, and assess competitive positioning
Report Format
PDF and XLSX data workbook (Word format preview document)
Publisher
Market Minds Advisory
Report Code
MMA-2026-AGR-408
Published
September 2026
Contact
sales@marketmindsadvisory.com | www.marketmindsadvisory.com

Purchase the full UK Animal Feed Alternative Protein Market Report (2026 to 2036).

The full report delivers a detailed assessment of the UK alternative protein market through 2036, covering protein source, species and regional forecasts, competitive benchmarking of leading integrated feed producers and novel protein specialists, and detailed input cost analysis. It combines MMA primary research, including a six-country survey of 3,800 respondents and 47 expert interviews, with public statistical and company data. Analysts also model production, regulatory and feedstock cost scenarios in depth. Clients receive segment margin ranges, approval trackers and a case study on alternative protein qualification strategy.
Ten-year protein source and species demand forecasts
Production, regulatory and feedstock cost tracking
Competitive benchmarking of leading UK protein suppliers
Novel food safety approval and regulatory tracker
Regional comparative analysis across the United Kingdom
Quarterly primary survey data update access

Built For The People Who Decide

From boardroom strategy to bench-side execution, this report is read cover-to-cover by leaders shaping the next decade of their industry, turning demand scenarios, market dynamics and valuation benchmarks into decisions.
CXOs/ Presidents/ VPs/ Managers
M&A and Corporate Development
Strategy Teams and R&D Heads
Procurement and Product Directors
Regulatory and Compliance Leaders
Investor Relations and Equity Analysts